DUBLIN--(BUSINESS WIRE)--The "Sinus Dilation Devices Market by Product (Balloon Dilation Devices, Endoscope (Rhinoscope, Sinoscope), Handheld), Procedure (Standalone, Hybrid), Patient Type (Adult, Pediatric) & Patient Care Setting (Hospitals & ASC, ENT Office) - Global Forecast to 2027" report has been added to ResearchAndMarkets.com's offering.
The global sinus dilation devices market is anticipated to reach USD 3.8 Billion by 2027 from USD 2.8 billion in 2022, at a CAGR of 6.6%
The growth of the market is primarily driven by the factors such as growing extensiveness of chronic sinusitis and rising inclination of minimally invasive surgeries such as balloon sinuplasty.
The Sinus stents/implants is projected to grow at highest CAGR of 8.2% from 2022 to 2027
Based on the product, the sinus dilation devices market is classified into Balloon sinus dilation devices, Endoscopes (Sinuscopes, Rhinoscopes), Sinus stents/implants, and Handheld instruments. The growth of this market is majorly driven by the factors such as Advantages of balloon dilation procedures compared to traditional endoscopic sinus surgeries and Elevated regularity in chronic sinusitis.
Asia Pacific is estimated to register the highest CAGR during the forecast period
In this report, the sinus dilation devices market is branched into four significant regional segments such as, North America, Europe, Asia Pacific, and the Rest of the World (RoW).
The market in Asia Pacific is projected to register the highest growth rate during the forecast period. The growth in this market is primarily driven by the rising geriatric population, increasing per capita income and presence of low cost treatments.
Competitive landscape
Prominent players in the sinus dilation devices market include Acclarent, Inc. (a subsidiary of Johnson & Johnson) (US), Olympus Corporation (Japan), F. Entellus Medical Inc. (a subsidiary of Stryker) (US), Medtronic plc (Ireland), Smith & Nephew plc (UK), Intersect ENT, Inc. (US), SinuSys Corporation (US), InnAccel Pvt. Ltd (India), Meril Life Sciences Pvt. Ltd. (India), and Optim LLC (US).
Premium Insights
- High Prevalence of Chronic Sinusitis to Drive Market
- Hospitals and ASCs Segment to Register Highest CAGR During Forecast Period
- Balloon Sinus Dilation Devices Segment to Dominate Asia-Pacific Market in 2022
- China to Register Highest CAGR During Forecast Period
Market Dynamics
Drivers
- High Prevalence of Chronic Sinusitis
- Benefits of Balloon Dilation Procedures Over Traditional Endoscopic Sinus Surgeries
- Growing Preference for Minimally Invasive Surgeries
- Rising Healthcare Expenditure
- Increasing Availability of Reimbursements
Restraints
- Risks Associated with Sinus Surgeries
- Availability of Non-Surgical Treatments for Chronic Sinusitis
Opportunities
- Growing Healthcare Market in Emerging Economies
Challenges
- Dearth of Skilled Otolaryngologists, ENT Surgeons, and Endoscopists
- Survival of Small Players and New Entrants
Company Profiles
- Acclarent, Inc. (Subsidiary of Johnson & Johnson)
- Angiplast Pvt. Ltd.
- Cook Medical
- Dalent Medical
- Emos Technology GmbH
- Entellus Medical, Inc. (Subsidiary of Stryker)
- Entermed
- Esc Medicams
- Innaccel Technologies Pvt Ltd.
- Intersect Ent, Inc.
- Jilin Coronado Medical Ltd.
- Karl Storz
- Maxer Endoscopy GmbH
- Medtronic plc
- Meril Life Sciences Pvt. Ltd.
- Olympus Corporation
- Optim LLC
- Pentax Medical
- Richard Wolf GmbH
- Scholly Fiberoptic GmbH
- Sinusys Corporation
- Sklar Surgical Instruments
- Smith & Nephew plc
- Summit Medical LLC
- Xion GmbH
For more information about this report visit https://www.researchandmarkets.com/r/mq62wx
